Ftse Mib
35.366,37
0,61%
DAX
18.869,36
0,78%
S&P 500
5.303,21
1,08%
NASDAQ
16.731,34
1,33%
Bitcoin
66.019,46
7,27%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ 10x Genomics Inc (TXG) 10x Genomics Inc (TXG) Notizie

TXG

10x Genomics (TXG)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TXG
DataOraFonteTitoloSimboloCompagnia
02/05/202422:05PR Newswire (US)10x Genomics to Present at the BofA Securities 2024 Healthcare ConferenceNASDAQ:TXG10x Genomics Inc
30/04/202422:05PR Newswire (US)10x Genomics Reports First Quarter 2024 Financial ResultsNASDAQ:TXG10x Genomics Inc
10/04/202422:05PR Newswire (US)10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024NASDAQ:TXG10x Genomics Inc
26/03/202414:00PR Newswire (US)10x Genomics Commercially Launches Visium HD Spatial Gene Expression AssayNASDAQ:TXG10x Genomics Inc
21/03/202421:05PR Newswire (US)10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene PanelNASDAQ:TXG10x Genomics Inc
13/03/202421:05PR Newswire (US)10x Genomics Begins Commercial Shipments of Chromium GEM-X ProductsNASDAQ:TXG10x Genomics Inc
06/03/202422:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
05/03/202400:40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
20/02/202422:05PR Newswire (US)10x Genomics to Present at the 44th Annual TD Cowen Health Care ConferenceNASDAQ:TXG10x Genomics Inc
15/02/202423:33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TXG10x Genomics Inc
15/02/202423:16Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TXG10x Genomics Inc
15/02/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXG10x Genomics Inc
15/02/202422:05PR Newswire (US)10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024NASDAQ:TXG10x Genomics Inc
07/02/202422:05PR Newswire (US)10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X TechnologyNASDAQ:TXG10x Genomics Inc
05/02/202422:05PR Newswire (US)10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General MeetingNASDAQ:TXG10x Genomics Inc
24/01/202422:05PR Newswire (US)10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024NASDAQ:TXG10x Genomics Inc
08/01/202415:00PR Newswire (US)10x Genomics Announces Preliminary Fourth Quarter and Full Year 2023 ResultsNASDAQ:TXG10x Genomics Inc
21/12/202322:05PR Newswire (US)10x Genomics to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TXG10x Genomics Inc
20/12/202322:05PR Newswire (US)10x Genomics Launches Xenium Catalyst NetworkNASDAQ:TXG10x Genomics Inc
19/12/202315:00PR Newswire (US)Integrative Study Conducted by 10x Genomics Combines Single Cell, Spatial and In Situ Analyses to Investigate Tumor InvasivenessNASDAQ:TXG10x Genomics Inc
13/12/202322:26PR Newswire (US)High Sensitivity and Specificity of the Xenium Platform from 10x Genomics Outperforms NanoString's CosMx and Vizgen's Merscope in Benchmarking PreprintNASDAQ:TXG10x Genomics Inc
07/12/202315:00PR Newswire (US)10x Genomics and NIH CARD to Create Comprehensive Single Cell Atlas of the Human BrainNASDAQ:TXG10x Genomics Inc
17/11/202323:22PR Newswire (US)10x Genomics Wins Another Patent Infringement Case Against NanoString TechnologiesNASDAQ:TXG10x Genomics Inc
06/11/202322:05PR Newswire (US)OWKIN Integrates 10x Genomics Spatial Omics and Single-Cell Technologies to the MOSAIC StudyNASDAQ:TXG10x Genomics Inc
02/11/202321:05PR Newswire (US)10x Genomics Reports Third Quarter 2023 Financial ResultsNASDAQ:TXG10x Genomics Inc
01/11/202321:05PR Newswire (US)10x Genomics to Present at the Stephens 25th Annual ConferenceNASDAQ:TXG10x Genomics Inc
26/10/202322:05PR Newswire (US)Study Fueled by Xenium Analysis Sheds Light on Resistance Mechanisms in Model of Lethal Pediatric Brain TumorsNASDAQ:TXG10x Genomics Inc
11/10/202322:05PR Newswire (US)10x Genomics to Report Third Quarter 2023 Financial Results on November 2, 2023NASDAQ:TXG10x Genomics Inc
10/10/202318:06PR Newswire (US)10x Genomics Comments on Second UPC Preliminary Injunction DecisionNASDAQ:TXG10x Genomics Inc
19/09/202319:08PR Newswire (US)10x Wins Injunction From Unified Patent Court Banning Sales of NanoString's CosMx Products in EuropeNASDAQ:TXG10x Genomics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TXG

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TIT
Telecom Italia
BIT
BPE
Bper Banca
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
BAMI
Banco BPM
BIT
STMMI
ST Microelectronics
BIT
MB
Mediobanca Banca di Cred...
BIT
PST
Poste Italiane S.p.a
BIT
A2A
A2A
BIT
LDO
Leonardo
BIT
IP
Interpump
BIT
G
Generali
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network